
There’s more good news in the battle against sickle cell disease, with another trial finding CRISPR gene-editing therapy delivering impressive results for patients. “It’s encouraging that this gene-editing treatment continues to show promising efficacy for sickle cell patients,” said study lead investigator Dr. Rabi Hanna. He’s chair of the division of pediatric hematology oncology and… read on > read on >